Ipsen To Exit Consumer Health And Focus On Specialty Pharma
In Talks To Sell Unit For €350m
The French group is sharpening its focus on specialty care in oncology, rare disease and neuroscience, so is looking to divest its consumer health division to Mayoly Spindler.
